Peter van Mourik

Comparison of organoid swelling and in vivo biomarkers of CFTR function to determine effects of lumacaftor- ivacaftor in patients with Cystic Fibrosis homozygous for the F508del mutation Peter van Mourik*, Simon Y. Graeber *, Annelotte M. Vonk, Evelien Kruisselbrink, Stephanie Hirtz, Cornelis K. van der Ent, Marcus A. Mall and Jeffrey M. Beekman * These authors contributed equally to this work American Journal of Respiratory and Critical Care Medicine 2020, In Press.